$67.95
0.06% today
Nasdaq, Aug 12, 10:00 pm CET
ISIN
US4364401012
Symbol
HOLX

Hologic Stock price

$67.99
+2.27 3.45% 1M
+3.52 5.46% 6M
-4.10 5.69% YTD
-13.78 16.85% 1Y
-4.08 5.66% 3Y
+2.20 3.34% 5Y
+26.75 64.86% 10Y
+56.43 488.02% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.07 0.10%

Key metrics

Basic
Market capitalization
$15.1b
Enterprise Value
$15.8b
Net debt
$643.4m
Cash
$1.9b
Shares outstanding
222.2m
Valuation (TTM | estimate)
P/E
27.5 | 15.9
P/S
3.7 | 3.6
EV/Sales
3.9 | 3.8
EV/FCF
17.2
P/B
3.1
Financial Health
Equity Ratio
56.0%
Return on Equity
15.4%
ROCE
12.6%
ROIC
12.5%
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
$4.0b | $4.2b
EBITDA
$1.0b | $1.4b
EBIT
$991.4m | $1.2b
Net Income
$557.1m | $947.9m
Free Cash Flow
$916.7m
Growth (TTM | estimate)
Revenue
1.3% | 3.1%
EBITDA
5.7% | 35.3%
EBIT
7.4% | 23.5%
Net Income
-20.6% | 20.1%
Free Cash Flow
-9.6%
Margin (TTM | estimate)
Gross
56.3%
EBITDA
25.0% | 32.5%
EBIT
24.6%
Net
13.8% | 22.8%
Free Cash Flow
22.7%
More
EPS
$2.5
FCF per Share
$4.1
Short interest
3.1%
Employees
7k
Rev per Employee
$570.0k
Show more

Is Hologic a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Hologic Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Hologic forecast:

12x Buy
43%
15x Hold
54%
1x Sell
4%

Analyst Opinions

28 Analysts have issued a Hologic forecast:

Buy
43%
Hold
54%
Sell
4%

Financial data from Hologic

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
4,039 4,039
1% 1%
100%
- Direct Costs 1,763 1,763
1% 1%
44%
2,276 2,276
3% 3%
56%
- Selling and Administrative Expenses 1,023 1,023
5% 5%
25%
- Research and Development Expense 244 244
12% 12%
6%
1,008 1,008
6% 6%
25%
- Depreciation and Amortization 16 16
46% 46%
0%
EBIT (Operating Income) EBIT 991 991
7% 7%
25%
Net Profit 557 557
21% 21%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Hologic directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hologic Stock News

Neutral
The Motley Fool
12 days ago
Hologic (HOLX) Q3 Revenue Beats 1%
Neutral
Seeking Alpha
13 days ago
Hologic, Inc. (NASDAQ:HOLX ) Q3 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants Essex D. Mitchell - Chief Operating Officer Karleen M.
Positive
Reuters
13 days ago
Medical equipment maker Hologic on Wednesday raised its annual profit forecast, anticipating strong demand for its molecular diagnostic devices and surgical products.
More Hologic News

Company Profile

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.

Head office United States
CEO Stephen MacMillan
Employees 7,063
Founded 1985
Website www.hologic.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today